References
- 1GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1459–1544. DOI: 10.1016/S0140-6736(16)31012-1
- 2Harding E. WHO global progress report on tuberculosis elimination. The Lancet Respiratory Medicine. 2020; 8(1): 19. DOI: 10.1016/S2213-2600(19)30418-7
- 3Faheem M, Hafizullah M, Gul A, Jan H, Khan M. Pattern of valvular lesions in rheumatic heart disease. J Postgrad Med Inst. 2007; 21(2).
- 4Chockalingam A, Gnanavelu G, Elangovan S, Chockalingam V. Clinical spectrum of chronic rheumatic heart disease in India. J Heart Valve Dis. 2003; 12(5): 577–581.
- 5Kingué S, Ba SA, Balde D, et al. The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 2016; 109(5): 321–329. DOI: 10.1016/j.acvd.2015.12.004
- 6El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era. JACC: Cardiovascular Imaging. 2018; 11(4): 628–643. DOI: 10.1016/j.jcmg.2018.01.009
- 7Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: Implications for management. Circulation. 2008; 118(22): 2298–2303. DOI: 10.1161/CIRCULATIONAHA.107.755942
- 8McCutcheon K, Manga P. Left ventricular remodelling in chronic primary mitral regurgitation: Implications for medical therapy. Cardiovasc J Afr. 2018; 29(1): 51–65. DOI: 10.5830/CVJA-2017-009
- 9Haddad F, Denault AY, Couture P, et al. Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr. 2007; 20(9): 1065–1072. DOI: 10.1016/j.echo.2007.02.017
- 10Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: A scientific statement from the American Heart Association. Circulation. 2015; 131(20): 1806–1818. DOI: 10.1161/CIR.0000000000000205
- 11Fraser WJ, Haffejee Z, Cooper K. Rheumatic Aschoff nodules revisited: An immunohistological reappraisal of the cellular component. Histopathology. 1995; 27(5): 457–461. DOI: 10.1111/j.1365-2559.1995.tb00310.x
- 12Putra TMH, Sukmawan R, Elen E, Atmadikoesoemah CA, Desandri DR, Kasim M. Prognostic value of late gadolinium enhancement in postoperative morbidity following mitral valve surgery in rheumatic mitral stenosis. Int J Angiol. 2019; 28(4): 237–244. DOI: 10.1055/s-0039-1693457
- 13Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16(3): 233–270. DOI: 10.1093/ehjci/jev014
- 14Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36): 2739–2791. DOI: 10.1093/eurheartj/ehx391
- 15Vahanian A, Alfieri O, Andreotti F, et al. [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome). 2013; 14(3): 167–214. DOI: 10.1714/1234.13659
- 16Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37(1): 67–119. DOI: 10.1093/eurheartj/ehv317
- 17Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—An evidence-based guideline. Nat Rev Cardiol. 2012; 9(5): 297–309. DOI: 10.1038/nrcardio.2012.7
- 18Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: A report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography. 2017; 30(4): 303–371. DOI: 10.1016/j.echo.2017.01.007
- 19Choi EY, Yoon SJ, Lim SH, et al. Detection of myocardial involvement of rheumatic heart disease with contrast-enhanced magnetic resonance imaging. Int J Cardiol. 2006; 113(2): e36–e38. DOI: 10.1016/j.ijcard.2006.04.013
- 20Su Q, Chen J, Fang Q. Modulation of the p38MAPK pathway in failing human myocardium secondary to rheumatic heart disease. J Heart Valve Dis. 2007; 16(6): 683–689.
- 21Williams RV, Minich LL, Shaddy RE, Veasy LG, Tani LY. Evidence for lack of myocardial injury in children with acute rheumatic carditis. Cardiol Young. 2002; 12(6): 519–523. DOI: 10.1017/S104795110200094X
- 22Gaasch WH, Folland ED. Left ventricular function in rheumatic mitral stenosis. Eur Heart J. 1991; 12(Suppl B): 66–69. DOI: 10.1093/eurheartj/12.suppl_B.66
- 23Beaton A, Richards H, Ploutz M, et al. Cardiac strain findings in children with latent rheumatic heart disease detected by echocardiographic screening. Cardiol Young. 2017; 27(6): 1180–1185. DOI: 10.1017/S1047951116002778
- 24Soesanto AM, Desandri DR, Haykal TM, Kasim M. Association between late gadolinium enhancement and global longitudinal strain in patients with rheumatic mitral stenosis. Int J Cardiovasc Imaging. 2019; 35(5): 781–789. DOI: 10.1007/s10554-018-1511-1
- 25Meel R, Peters F, Libhaber E, Essop ME. Unmasking right ventricular dysfunction in chronic rheumatic mitral regurgitation. Cardiovasc J Afr. 2019; 30(4): 216–221. DOI: 10.5830/CVJA-2019-020